Date:October 30, 2012

Mary Hurwitz, PhD

Mary Hurwitz, Ph.D.Associate Professor
Department of Pediatrics
Section of Hematology-Oncology
Baylor College of Medicine

Dr. Mary Hurwitz
Texas Children’s Cancer Center
1102 Bates Street, Suite 1025.22
Houston, TX 77030

Phone: 832-824-4257
Fax: 832-825-4846


Dr. Mary Hurwitz is involved in pre-clinical and translational studies of the use of gene therapy for ocular disorders. Using both in vitro and in vivo models of retinoblastoma, studies have been designed to examine viral-mediated gene therapy for the treatment of tumors in the eye. These studies include 1) elucidation of the unique properties of adenoviral transduction in the ocular environment; 2) investigation of immune consequences of adenoviral-mediated gene transfer; 3) elucidation of the differences between metastatic and non-metastatic tumor development; and 4) characterization of stem cell populations in retinoblastoma tumors and cell lines derived from those tumors.


Ph.D., University of Minnesota
Fellowship, University of Washington

Selected Memberships

Member, Association for Research in Vision and Ophthalmology (ARVO)
Member, American Society of Gene Therapy (ASGT)
Member, American Society for Biochemistry and Molecular Biology (ASBMB)
Member, American Society for Cell Biology (ASCB)
Member, International Society for Ocular Oncology
Member, International Society for Genetic Eye Diseases and Retinoblastoma

Clinical Interests

Ocular Disorders

Research Interests

Gene therapy for ocular disorders

 Learn about the Research Laboratory of Mary Hurwitz